160 related articles for article (PubMed ID: 34352467)
1. BAFF signaling in health and disease.
Schweighoffer E; Tybulewicz VL
Curr Opin Immunol; 2021 Aug; 71():124-131. PubMed ID: 34352467
[TBL] [Abstract][Full Text] [Related]
2. Critical requirement for BCR, BAFF, and BAFFR in memory B cell survival.
Müller-Winkler J; Mitter R; Rappe JCF; Vanes L; Schweighoffer E; Mohammadi H; Wack A; Tybulewicz VLJ
J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33119032
[TBL] [Abstract][Full Text] [Related]
3. The BAFF receptor transduces survival signals by co-opting the B cell receptor signaling pathway.
Schweighoffer E; Vanes L; Nys J; Cantrell D; McCleary S; Smithers N; Tybulewicz VL
Immunity; 2013 Mar; 38(3):475-88. PubMed ID: 23453634
[TBL] [Abstract][Full Text] [Related]
4. B cell activation through CD40 and IL4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRIL.
Ferrer G; Bosch R; Hodgson K; Tejero R; Roué G; Colomer D; Montserrat E; Moreno C
Br J Haematol; 2014 Feb; 164(4):570-8. PubMed ID: 24245956
[TBL] [Abstract][Full Text] [Related]
5. BAFFR activates PI3K/AKT signaling in human naive but not in switched memory B cells through direct interactions with B cell antigen receptors.
Sevdali E; Block V; Lataretu M; Li H; Smulski CR; Briem JS; Heitz Y; Fischer B; Ramirez NJ; Grimbacher B; Jäck HM; Voll RE; Hölzer M; Schneider P; Eibel H
Cell Rep; 2022 Jun; 39(13):111019. PubMed ID: 35767961
[TBL] [Abstract][Full Text] [Related]
6. Signalling crosstalk in B cells: managing worth and need.
Cancro MP
Nat Rev Immunol; 2009 Sep; 9(9):657-61. PubMed ID: 19704418
[TBL] [Abstract][Full Text] [Related]
7. SYK inhibition thwarts the BAFF - B-cell receptor crosstalk and thereby antagonizes Mcl-1 in chronic lymphocytic leukemia.
Paiva C; Rowland TA; Sreekantham B; Godbersen C; Best SR; Kaur P; Loriaux MM; Spurgeon SEF; Danilova OV; Danilov AV
Haematologica; 2017 Nov; 102(11):1890-1900. PubMed ID: 28838991
[TBL] [Abstract][Full Text] [Related]
8. BAFF receptor signaling aids the differentiation of immature B cells into transitional B cells following tonic BCR signaling.
Rowland SL; Leahy KF; Halverson R; Torres RM; Pelanda R
J Immunol; 2010 Oct; 185(8):4570-81. PubMed ID: 20861359
[TBL] [Abstract][Full Text] [Related]
9. Roles of TRAFs in NF-κB signaling pathways mediated by BAFF.
Tang X; Zhang L; Wei W
Immunol Lett; 2018 Apr; 196():113-118. PubMed ID: 29378215
[TBL] [Abstract][Full Text] [Related]
10. BAFF receptor polymorphisms and deficiency in humans.
Sevdali E; Block Saldana V; Speletas M; Eibel H
Curr Opin Immunol; 2021 Aug; 71():103-110. PubMed ID: 34311146
[TBL] [Abstract][Full Text] [Related]
11. Comment on "Soluble BAFF levels inversely correlate with peripheral B cell numbers and the expression of BAFF receptors".
Ferrer G; Moreno C; Montserrat E
J Immunol; 2012 Apr; 188(7):2930-1; author reply 2931. PubMed ID: 22442489
[No Abstract] [Full Text] [Related]
12. BAFFR controls early memory B cell responses but is dispensable for germinal center function.
Lau AWY; Turner VM; Bourne K; Hermes JR; Chan TD; Brink R
J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33119033
[TBL] [Abstract][Full Text] [Related]
13. BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway.
Endo T; Nishio M; Enzler T; Cottam HB; Fukuda T; James DF; Karin M; Kipps TJ
Blood; 2007 Jan; 109(2):703-10. PubMed ID: 16973958
[TBL] [Abstract][Full Text] [Related]
14. DYRK1a mediates BAFF-induced noncanonical NF-κB activation to promote autoimmunity and B-cell leukemogenesis.
Li Y; Xie X; Jie Z; Zhu L; Yang JY; Ko CJ; Gao T; Jain A; Jung SY; Baran N; Konopleva MY; Cheng X; Sun SC
Blood; 2021 Dec; 138(23):2360-2371. PubMed ID: 34255829
[TBL] [Abstract][Full Text] [Related]
15. An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathway.
Morrison MD; Reiley W; Zhang M; Sun SC
J Biol Chem; 2005 Mar; 280(11):10018-24. PubMed ID: 15644327
[TBL] [Abstract][Full Text] [Related]
16. Altered BAFF-receptor signaling and additional modifier loci contribute to systemic autoimmunity in A/WySnJ mice.
Mayne CG; Nashold FE; Sasaki Y; Hayes CE
Eur J Immunol; 2009 Feb; 39(2):589-99. PubMed ID: 19152335
[TBL] [Abstract][Full Text] [Related]
17. Context-specific BAFF-R signaling by the NF-κB and PI3K pathways.
Jellusova J; Miletic AV; Cato MH; Lin WW; Hu Y; Bishop GA; Shlomchik MJ; Rickert RC
Cell Rep; 2013 Nov; 5(4):1022-35. PubMed ID: 24239354
[TBL] [Abstract][Full Text] [Related]
18. B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia.
Zhang W; Kater AP; Widhopf GF; Chuang HY; Enzler T; James DF; Poustovoitov M; Tseng PH; Janz S; Hoh C; Herschman H; Karin M; Kipps TJ
Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18956-60. PubMed ID: 20956327
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in genes of the BAFF/APRIL system may constitute risk factors of B-CLL--a preliminary study on a Polish population.
Jasek M; Wagner M; Sobczynski M; Wolowiec D; Kuliczkowski K; Woszczyk D; Kielbinski M; Kusnierczyk P; Frydecka I; Karabon L
Tissue Antigens; 2015 Oct; 86(4):279-84. PubMed ID: 26268376
[TBL] [Abstract][Full Text] [Related]
20. CVID-Associated B Cell Activating Factor Receptor Variants Change Receptor Oligomerization, Ligand Binding, and Signaling Responses.
Block V; Sevdali E; Recher M; Abolhassani H; Hammarstrom L; Smulski CR; Baronio M; Plebani A; Proietti M; Speletas M; Warnatz K; Voll RE; Lougaris V; Schneider P; Eibel H
J Clin Immunol; 2023 Feb; 43(2):391-405. PubMed ID: 36308663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
